THRX 12.99 Theravance $THRX Hit a 52 week low of 1
Post# of 42
Posted On: 11/12/2014 11:34:33 AM
THRX 12.99 Theravance $THRX Hit a 52 week low of 12.78 Closing the day 10:44 at 12.99 +0.06 +0.46% With a day low of 12.78 and a total volume of 87,058.
THRX Recent Posts: http://investorshangout.com/Theravance-THRX-55637/
THRX Theravance Recent Headline News
When Is It Time To Accumulate Theravance?
Chris Lau - at Seeking Alpha - Tue Nov 11, 10:50AM CST
MRK: 59.20 (-0.17), AZN: 74.10 (-0.10), THRX: 13.00 (+0.07), TBPH: 17.63 (-0.33), GSK: 45.63 (-0.33)
Sanofi/Regeneron asthma drug successful in Phase 2 trial
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 6:44AM CST
MRK: 59.20 (-0.17), AZN: 74.10 (-0.10), AMGN: 161.33 (-1.09), TEVA: 58.13 (-0.06), THRX: 13.00 (+0.07), GSK: 45.63 (-0.33), SNY: 46.61 (-0.53), REGN: 399.83 (+1.47), NVS: 92.69 (-0.08)
Theravance Biopharma Q3 Loss Widens Y/Y, Revenues Beat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 10:20AM CST
Theravance Biopharma reported a third-quarter 2014 loss of $1.72 per share.
AMAG: 34.74 (-0.14), TBPH: 17.63 (-0.33), GSK: 45.63 (-0.33), THRX: 13.00 (+0.07)
Shares of THRX Down 47.9% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Fri Nov 07, 9:10AM CST
SmarTrend identified a Downtrend for Theravance (NASDAQ:THRX) on July 18th, 2014 at $27.33. In approximately 4 months, Theravance has returned 47.93% as of today's recent price of $14.23.
THRX: 13.00 (+0.07)
5 Stocks With Big Insider Buying in November: NuStar, Huntsman and More
at The Street - Thu Nov 06, 11:45AM CST
Insiders usually buy their own shares for one reason: They think the stock is a bargain and has tremendous upside.
SCCO: 30.08 (-0.15), WRLD: 76.38 (-1.16), NS: 60.10 (-0.62), THRX: 13.00 (+0.07), HUN: 24.76 (-0.43)
Theravance to Present at Two Upcoming Investor Conferences in November
Marketwired - Wed Nov 05, 3:08PM CST
Theravance, Inc. (NASDAQ: THRX) today announced Michael W. Aguiar, President and Chief Executive Officer of Theravance, will be presenting at two upcoming investor conferences in November.
THRXV: 28.00 (+7.07), THRX: 13.00 (+0.07)
Real Money's Brian Sozzi: A Primer on Investing in Retail Stocks
at The Street - Wed Nov 05, 11:38AM CST
Some thoughts on the outlook of the retail sector and what to look for before you invest.
COH: 34.76 (+0.47), TJX: 63.46 (+0.21), NKE: 94.78 (-0.10), TGT: 66.08 (+0.36), WMT: 79.06 (+0.05), HBI: 109.54 (+0.65), THRX: 13.00 (+0.07), KORS: 69.82 (+0.93), GPS: 38.78 (-0.04), RL: 170.49 (-0.58), LULU: 44.07 (+0.89)
InsiderInsights.com Daily Round Up 11/4/14: UFI, SABA, CCI
InsiderInsights - at Seeking Alpha - Wed Nov 05, 8:31AM CST
CCI: 79.92 (+0.31), CBG: 32.54 (-0.10), HGG: 5.63 (-0.05), LLY: 67.44 (-0.41), BA: 125.45 (+0.09), MAR: 76.80 (-0.34), QNST: 4.17 (-0.16), OZRK: 36.41 (-0.01), APO: 22.93 (-0.59), STAA: 8.85 (-0.02), AMBR: 11.29 (-0.15), FSAM: 13.67 (+0.14), WRLD: 76.38 (-1.16), CPLA: 69.01 (+0.43), THRX: 13.00 (+0.07), MSFT: 48.71 (-0.16), UFI: 27.10 (-0.42), AN: 58.11 (+0.24), CRM: 63.35 (-0.71)
FDA accepts BI's Spiriva NDA for asthma
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 12:06PM CST
AZN: 74.10 (-0.10), TEVA: 58.13 (-0.06), GSK: 45.63 (-0.33), THRX: 13.00 (+0.07), SNY: 46.61 (-0.53), REGN: 399.83 (+1.47), NVS: 92.69 (-0.08)
7 Old Dividend Dogs Of Healthcare Aim At 11% To 30.5% October Upsides
Fredrik Arnold - at Seeking Alpha - Mon Nov 03, 11:21AM CST
KND: 20.53 (+0.04), VIVO: 16.99 (+0.08), PETS: 13.66 (+0.06), PFE: 30.45 (+0.13), GSK: 45.63 (-0.33), MR: 31.17 (+0.31), SEM: 13.58 (+0.04), PDLI: 8.02 (-0.09), SNN: 33.48 (-0.43), AZN: 74.10 (-0.10), MRK: 59.21 (-0.16), STJ: 65.27 (-0.51), TRIB: 18.12 (-0.14), ABBV: 63.84 (-0.01), THRX: 13.00 (+0.07), SNY: 46.61 (-0.53)
Theravance (THRX) Falls on Wider-than-Expected Loss in Q3 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 8:10AM CST
Theravance reported third-quarter 2014 loss of 19 cents per share.
AMAG: 34.74 (-0.14), TBPH: 17.63 (-0.33), GSK: 45.63 (-0.33), THRX: 13.00 (+0.07)
Bayer Q3 Earnings Grow Y/Y on New Product Sales, View Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 8:00AM CST
Bayer's (BAYRY) earnings during the third quarter of 2014 came in at roughly $1.79 per share.
MRK: 59.21 (-0.16), AMAG: 34.74 (-0.14), THRX: 13.00 (+0.07)
Update: GSK Starts Promoting Theravance Drugs More Actively
Early Retiree - at Seeking Alpha - Sat Nov 01, 7:42AM CDT
THRX: 13.00 (+0.07), GSK: 45.63 (-0.33)
More on Theravance Q3 results
Seeking Alpha - at Seeking Alpha - Fri Oct 31, 1:03PM CDT
THRX: 13.00 (+0.07)
Theravance misses Street 3Q forecasts
Automated Insights - Fri Oct 31, 4:04AM CDT
SOUTH SAN FRANCISCO, Calif. (AP) _ Theravance Inc. (THRX) on Friday reported a third-quarter loss of $21.3 million.
THRXV: 28.00 (+7.07), THRX: 13.00 (+0.07)
Theravance's (THRX) CEO Mike Aguiar on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 30, 10:27PM CDT
THRX: 13.00 (+0.07)
Theravance declares $0.25 dividend
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 5:49PM CDT
THRX: 13.00 (+0.07)
Theravance Has Returned 40.7% Since SmarTrend Recommendation (THRX)
Comtex SmarTrend(R) - Thu Oct 30, 4:38PM CDT
SmarTrend identified a Downtrend for Theravance (NASDAQ:THRX) on July 18th, 2014 at $27.33. In approximately 3 months, Theravance has returned 40.69% as of today's recent price of $16.21.
THRX: 13.00 (+0.07)
Theravance (THRX) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Oct 30, 3:55PM CDT
THRX: 13.00 (+0.07)
Theravance misses by $0.05, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 3:26PM CDT
THRX: 13.00 (+0.07)
THRX Recent Posts: http://investorshangout.com/Theravance-THRX-55637/
THRX Theravance Recent Headline News
When Is It Time To Accumulate Theravance?
Chris Lau - at Seeking Alpha - Tue Nov 11, 10:50AM CST
MRK: 59.20 (-0.17), AZN: 74.10 (-0.10), THRX: 13.00 (+0.07), TBPH: 17.63 (-0.33), GSK: 45.63 (-0.33)
Sanofi/Regeneron asthma drug successful in Phase 2 trial
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 6:44AM CST
MRK: 59.20 (-0.17), AZN: 74.10 (-0.10), AMGN: 161.33 (-1.09), TEVA: 58.13 (-0.06), THRX: 13.00 (+0.07), GSK: 45.63 (-0.33), SNY: 46.61 (-0.53), REGN: 399.83 (+1.47), NVS: 92.69 (-0.08)
Theravance Biopharma Q3 Loss Widens Y/Y, Revenues Beat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 10:20AM CST
Theravance Biopharma reported a third-quarter 2014 loss of $1.72 per share.
AMAG: 34.74 (-0.14), TBPH: 17.63 (-0.33), GSK: 45.63 (-0.33), THRX: 13.00 (+0.07)
Shares of THRX Down 47.9% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Fri Nov 07, 9:10AM CST
SmarTrend identified a Downtrend for Theravance (NASDAQ:THRX) on July 18th, 2014 at $27.33. In approximately 4 months, Theravance has returned 47.93% as of today's recent price of $14.23.
THRX: 13.00 (+0.07)
5 Stocks With Big Insider Buying in November: NuStar, Huntsman and More
at The Street - Thu Nov 06, 11:45AM CST
Insiders usually buy their own shares for one reason: They think the stock is a bargain and has tremendous upside.
SCCO: 30.08 (-0.15), WRLD: 76.38 (-1.16), NS: 60.10 (-0.62), THRX: 13.00 (+0.07), HUN: 24.76 (-0.43)
Theravance to Present at Two Upcoming Investor Conferences in November
Marketwired - Wed Nov 05, 3:08PM CST
Theravance, Inc. (NASDAQ: THRX) today announced Michael W. Aguiar, President and Chief Executive Officer of Theravance, will be presenting at two upcoming investor conferences in November.
THRXV: 28.00 (+7.07), THRX: 13.00 (+0.07)
Real Money's Brian Sozzi: A Primer on Investing in Retail Stocks
at The Street - Wed Nov 05, 11:38AM CST
Some thoughts on the outlook of the retail sector and what to look for before you invest.
COH: 34.76 (+0.47), TJX: 63.46 (+0.21), NKE: 94.78 (-0.10), TGT: 66.08 (+0.36), WMT: 79.06 (+0.05), HBI: 109.54 (+0.65), THRX: 13.00 (+0.07), KORS: 69.82 (+0.93), GPS: 38.78 (-0.04), RL: 170.49 (-0.58), LULU: 44.07 (+0.89)
InsiderInsights.com Daily Round Up 11/4/14: UFI, SABA, CCI
InsiderInsights - at Seeking Alpha - Wed Nov 05, 8:31AM CST
CCI: 79.92 (+0.31), CBG: 32.54 (-0.10), HGG: 5.63 (-0.05), LLY: 67.44 (-0.41), BA: 125.45 (+0.09), MAR: 76.80 (-0.34), QNST: 4.17 (-0.16), OZRK: 36.41 (-0.01), APO: 22.93 (-0.59), STAA: 8.85 (-0.02), AMBR: 11.29 (-0.15), FSAM: 13.67 (+0.14), WRLD: 76.38 (-1.16), CPLA: 69.01 (+0.43), THRX: 13.00 (+0.07), MSFT: 48.71 (-0.16), UFI: 27.10 (-0.42), AN: 58.11 (+0.24), CRM: 63.35 (-0.71)
FDA accepts BI's Spiriva NDA for asthma
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 12:06PM CST
AZN: 74.10 (-0.10), TEVA: 58.13 (-0.06), GSK: 45.63 (-0.33), THRX: 13.00 (+0.07), SNY: 46.61 (-0.53), REGN: 399.83 (+1.47), NVS: 92.69 (-0.08)
7 Old Dividend Dogs Of Healthcare Aim At 11% To 30.5% October Upsides
Fredrik Arnold - at Seeking Alpha - Mon Nov 03, 11:21AM CST
KND: 20.53 (+0.04), VIVO: 16.99 (+0.08), PETS: 13.66 (+0.06), PFE: 30.45 (+0.13), GSK: 45.63 (-0.33), MR: 31.17 (+0.31), SEM: 13.58 (+0.04), PDLI: 8.02 (-0.09), SNN: 33.48 (-0.43), AZN: 74.10 (-0.10), MRK: 59.21 (-0.16), STJ: 65.27 (-0.51), TRIB: 18.12 (-0.14), ABBV: 63.84 (-0.01), THRX: 13.00 (+0.07), SNY: 46.61 (-0.53)
Theravance (THRX) Falls on Wider-than-Expected Loss in Q3 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 8:10AM CST
Theravance reported third-quarter 2014 loss of 19 cents per share.
AMAG: 34.74 (-0.14), TBPH: 17.63 (-0.33), GSK: 45.63 (-0.33), THRX: 13.00 (+0.07)
Bayer Q3 Earnings Grow Y/Y on New Product Sales, View Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 8:00AM CST
Bayer's (BAYRY) earnings during the third quarter of 2014 came in at roughly $1.79 per share.
MRK: 59.21 (-0.16), AMAG: 34.74 (-0.14), THRX: 13.00 (+0.07)
Update: GSK Starts Promoting Theravance Drugs More Actively
Early Retiree - at Seeking Alpha - Sat Nov 01, 7:42AM CDT
THRX: 13.00 (+0.07), GSK: 45.63 (-0.33)
More on Theravance Q3 results
Seeking Alpha - at Seeking Alpha - Fri Oct 31, 1:03PM CDT
THRX: 13.00 (+0.07)
Theravance misses Street 3Q forecasts
Automated Insights - Fri Oct 31, 4:04AM CDT
SOUTH SAN FRANCISCO, Calif. (AP) _ Theravance Inc. (THRX) on Friday reported a third-quarter loss of $21.3 million.
THRXV: 28.00 (+7.07), THRX: 13.00 (+0.07)
Theravance's (THRX) CEO Mike Aguiar on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 30, 10:27PM CDT
THRX: 13.00 (+0.07)
Theravance declares $0.25 dividend
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 5:49PM CDT
THRX: 13.00 (+0.07)
Theravance Has Returned 40.7% Since SmarTrend Recommendation (THRX)
Comtex SmarTrend(R) - Thu Oct 30, 4:38PM CDT
SmarTrend identified a Downtrend for Theravance (NASDAQ:THRX) on July 18th, 2014 at $27.33. In approximately 3 months, Theravance has returned 40.69% as of today's recent price of $16.21.
THRX: 13.00 (+0.07)
Theravance (THRX) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Oct 30, 3:55PM CDT
THRX: 13.00 (+0.07)
Theravance misses by $0.05, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 3:26PM CDT
THRX: 13.00 (+0.07)
(0)
(0)Innoviva, Inc. (INVA) Stock Research Links
Scroll down for more posts ▼